The FDA announced revocation of the Emergency Use Authorization for the xMAP MultiFLEX Zika RNA Assay at the request of the manufacturer, Luminex Corporation, following Luminex’s decision to discontinue the product. Read the FDA notice and Luminex request letter.
-
- Overview
- Developmental path of the infection preventionist
- Infection preventionist (IP) competency model
- APIC Fellows Program
- Implementation guides
- Practice resources
- Scientific guidelines
- Research
- Emergency preparedness
- AJIC
- International Infection Prevention Week
- Practice Guidance Committee Activities
